Full Text View
Tabular View
No Study Results Posted
Related Studies
Selegiline for Smoking Cessation - 1
This study has been completed.
Study NCT00439413   Information provided by National Institute on Drug Abuse (NIDA)
First Received: February 22, 2007   Last Updated: January 26, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nicotine Dependence
Additional conditions recognized in this trial
Tobacco Use Disorder
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Selegiline
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Monoamine Oxidase Inhibitors
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
Department of Veterans Affairs


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services